NO164101C - Analogifremgangsmaate for fremstilling av terapeutisk aktive tetracykliske spiro-hydantoin-derivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive tetracykliske spiro-hydantoin-derivater.Info
- Publication number
- NO164101C NO164101C NO86861425A NO861425A NO164101C NO 164101 C NO164101 C NO 164101C NO 86861425 A NO86861425 A NO 86861425A NO 861425 A NO861425 A NO 861425A NO 164101 C NO164101 C NO 164101C
- Authority
- NO
- Norway
- Prior art keywords
- conh
- chem
- disclosed
- derivatives
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/16—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/88—Unsaturated compounds containing keto groups containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1984/001290 WO1986001107A1 (en) | 1984-08-14 | 1984-08-14 | Tetracyclic spiro-hydantoin aldose reductase inhibitors, compositions and methods of making |
Publications (3)
Publication Number | Publication Date |
---|---|
NO861425L NO861425L (no) | 1986-04-11 |
NO164101B NO164101B (no) | 1990-05-21 |
NO164101C true NO164101C (no) | 1990-08-29 |
Family
ID=22182231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO86861425A NO164101C (no) | 1984-08-14 | 1986-04-11 | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetracykliske spiro-hydantoin-derivater. |
Country Status (24)
Country | Link |
---|---|
US (1) | US4656169A (xx) |
EP (1) | EP0173497B1 (xx) |
JP (1) | JPS6147486A (xx) |
KR (1) | KR870000624B1 (xx) |
AT (1) | ATE46162T1 (xx) |
AU (1) | AU553699B2 (xx) |
CA (1) | CA1255304A (xx) |
DD (1) | DD236529A5 (xx) |
DE (1) | DE3572818D1 (xx) |
DK (1) | DK366685A (xx) |
ES (2) | ES8704495A1 (xx) |
FI (1) | FI82695C (xx) |
GR (1) | GR851968B (xx) |
IE (1) | IE58123B1 (xx) |
IL (1) | IL76076A0 (xx) |
IN (2) | IN166581B (xx) |
NO (1) | NO164101C (xx) |
NZ (1) | NZ213085A (xx) |
PH (1) | PH22910A (xx) |
PL (2) | PL145221B1 (xx) |
PT (1) | PT80940B (xx) |
WO (1) | WO1986001107A1 (xx) |
YU (1) | YU44894B (xx) |
ZA (1) | ZA856102B (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5202339A (en) * | 1987-08-28 | 1993-04-13 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
US5004751A (en) * | 1987-08-28 | 1991-04-02 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
WO1990002126A1 (en) * | 1988-08-24 | 1990-03-08 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
TW202450B (xx) * | 1991-06-26 | 1993-03-21 | Dainippon Pharmaceutical Co |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3821383A (en) * | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
US4193996A (en) * | 1979-04-04 | 1980-03-18 | Pfizer Inc. | Spiro-quinolone hydantoins |
US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
-
1984
- 1984-08-14 US US06/854,588 patent/US4656169A/en not_active Expired - Fee Related
- 1984-08-14 WO PCT/US1984/001290 patent/WO1986001107A1/en active IP Right Grant
-
1985
- 1985-07-15 IN IN552/DEL/85A patent/IN166581B/en unknown
- 1985-08-08 AT AT85305636T patent/ATE46162T1/de not_active IP Right Cessation
- 1985-08-08 EP EP85305636A patent/EP0173497B1/en not_active Expired
- 1985-08-08 DE DE8585305636T patent/DE3572818D1/de not_active Expired
- 1985-08-12 GR GR851968A patent/GR851968B/el unknown
- 1985-08-12 CA CA000488544A patent/CA1255304A/en not_active Expired
- 1985-08-12 DD DD85279599A patent/DD236529A5/de not_active IP Right Cessation
- 1985-08-12 PT PT80940A patent/PT80940B/pt not_active IP Right Cessation
- 1985-08-12 IL IL76076A patent/IL76076A0/xx not_active IP Right Cessation
- 1985-08-12 ES ES546093A patent/ES8704495A1/es not_active Expired
- 1985-08-12 JP JP60177463A patent/JPS6147486A/ja active Granted
- 1985-08-13 PL PL1985254960A patent/PL145221B1/pl unknown
- 1985-08-13 ZA ZA856102A patent/ZA856102B/xx unknown
- 1985-08-13 AU AU46126/85A patent/AU553699B2/en not_active Ceased
- 1985-08-13 DK DK366685A patent/DK366685A/da not_active Application Discontinuation
- 1985-08-13 KR KR1019850005822A patent/KR870000624B1/ko not_active IP Right Cessation
- 1985-08-13 IE IE199185A patent/IE58123B1/en not_active IP Right Cessation
- 1985-08-13 PL PL1985261413A patent/PL147875B1/pl unknown
- 1985-08-13 YU YU1290/85A patent/YU44894B/xx unknown
- 1985-08-13 NZ NZ213085A patent/NZ213085A/en unknown
- 1985-08-14 PH PH32632A patent/PH22910A/en unknown
-
1986
- 1986-02-13 ES ES551963A patent/ES8801831A1/es not_active Expired
- 1986-04-11 NO NO86861425A patent/NO164101C/no unknown
- 1986-04-11 FI FI861544A patent/FI82695C/fi not_active IP Right Cessation
-
1987
- 1987-06-17 IN IN522/DEL/87A patent/IN166590B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK561485D0 (da) | Vitamin d3 derivater substitueret ved 2-stillingen | |
YU53700A (sh) | Biciklo(2.2.1.) heptani i srodna jedinjenja | |
ATE259826T1 (de) | Glycinamidederivate mit funktionalisierter alkyl- und alkenylseitenkette als inhibitoren der farnesyltransferase | |
ATE117979T1 (de) | Isoprenoide phospholipase a2 inhibitoren und sie enthaltende zusammensetzungen. | |
NO164101C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetracykliske spiro-hydantoin-derivater. | |
DE3780778D1 (de) | Topisches arzneimittel enthaltend 17-beta-methoxy-carbonyl-4-methyl-4-aza-5-alpha-androst-1-en-3-one. | |
PT87277A (pt) | Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same | |
DK89182A (da) | Fremgangsmaade til fremstilling af n-naphthoylglycinderivater | |
JPS5681578A (en) | Novel thioalkyl amide derivative | |
MY131544A (en) | Fluorinated 4-aminoandrostadienone derivatives and process for their preparation | |
ES2193168T3 (es) | Nuevos derivados de acido parabanico como inhibidores de aldosa reductasa. | |
EA199900460A1 (ru) | Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные |